Comments from Speaker
Discover how AI-predicted protein structures are reshaping the biotech IP landscape in Japan. As AlphaFold has revolutionized structural biology, AI-driven protein structure predictions have reached unprecedented level of accuracy. Given the JPO’s strict enablement and written-description requirements, navigating patentability in Japan is critical for foreign practitioners.
This webinar covers cutting-edge strategies: integrating in silico data to satisfy JPO standards, leveraging trade secrets for AI platforms, and drafting robust claims. We will also explore how rapid technological advances may reshape examination guidelines and JPO practice.
Note
- This webinar is aimed at providing IP information to our business partners and clients from overseas. Registration from persons who work for IP firms or law firms in Japan will not be approved as this may be deemed as a conflict of interest with our business.
- You will receive a confirmation mail after you have registered.
- If you miss watching the live session, you will receive an on-demand recorded video link a day after the live session is over.